[Current therapy of nephrotic syndrome].
The etiology and therapy of the nephrotic syndrome are reviewed. Current therapeutic procedures include symptomatic and causal treatment with steroids and/or cytotoxic drugs, as well as some new modalities of therapy.
D000925:Anticoagulants / Q000627:therapeutic use; D003131:Combined Modality Therapy; D004039:Diet, Sodium-Restricted; D004232:Diuretics / Q000627:therapeutic use; D005921:Glomerulonephritis / Q000188:drug therapy; D006801:Humans; D000960:Hypolipidemic Agents / Q000627:therapeutic use; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D009402:Nephrosis, Lipoid / Q000188:drug therapy; D009404:Nephrotic Syndrome / Q000188:drug therapy* / Q000209:etiology; D010951:Plasma Exchange; D011241:Prednisone / Q000627:therapeutic use; D011379:Prognosis; D012709:Serum Albumin / Q000008:administration & dosage
D000925:Anticoagulants; D004232:Diuretics; D000960:Hypolipidemic Agents; D007166:Immunosuppressive Agents; D012709:Serum Albumin; D011241:Prednisone
Aktuelle Therapie des nephrotischen Syndroms.